News

"If patients have one feature, that is bad, and if they have two or more, that is really bad," he said. "Regardless of ...
Gail Whiteford battled for four years to get the diagnosis with symptoms like back ache, excessive urinating, blood in her ...
AbbVie will be gaining rights to IGI Therapeutics’ lead candidate for oncology and autoimmune diseases in an exclusive ...
MiROM identifies proteins by using mid-infrared light to detect molecular vibrations – essentially the natural "dance" of molecules within protein structures. Unlike optical spectroscopy, which ...
Glenmark’s outlicensing deal with AbbVie for a novel drug for blood cancer under development sets a new course for the ...
Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...